Learn about Cannabinol, CBN, Rare Cannabinoids, EB, Glaucoma

Skip to content

Facebook Twitter Linkedin

Pharmaceutical
Manufacturing
Investors
Corporate
Learn

Menu

Pharmaceutical
Manufacturing
Investors
Corporate
Learn

Latest Events

VirtualInvestorConferences.com – Life Sciences Investor Forum

Date: March 9, 2023

Time: 11:00am ET

Add to Calendar

Emerging Growth Conference

Date: March 8, 2023

Time: 12:30pm ET

Add to Calendar

Tribe Public’s Webinar Event “Exploring the Neuroprotective Qualities of Rare Cannabinoids”

Date: November 17, 2022

Time: 8am PT / 11am ET

Add to Calendar

Force For Knowledge Cannabis Symposium – Jump Starting Cannabis Valuations 101

Date: June 29, 2022

Time: 12:00pm ET

Add to Calendar

H.C. Wainwright Global Investment Conference

Date: May 23-26, 2022

Add to Calendar

Canaccord Genuity’s 6th Annual Global Cannabis Conference

Date: May 11, 2022

Add to Calendar

Management

Board of Directors

Scientific Advisory Board

Investor Alerts

Sign up to receive news releases from InMed Pharmaceuticals.

#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4

Pharmaceutical

Cannabinoids in Development
INM-755 for Epidermolysis Bullosa
INM-088 for Glaucoma
Neurodegenerative Disease
Novel Cannabinoid Analogs

MANUFACTURING

Cannabinoid Manufacturing Expertise
IntegraSyn™ Cannabinoid Manufacturing
BayMedica Cannabinoid Biosynthesis
Rare Cannabinoid Ingredients

Investor

News
Events
Stock Information
Corporate Governance
Financials & AGM
Filings
Presentations
Media

CORPORATE

Management
Board of Directors
Scientific Advisory Board
Partners and Collaborators
Careers
Contact

Learn

What is Cannabinol (CBN)?
What is Epidermolysis Bullosa (EB)?
What is Glaucoma?
Cannabinoid Manufacturing Economics 101
GMP Manufacturing Standards by Product Type
Cannabinoids for Glaucoma
Cannabinoid Science
Articles and Videos

© Copyright 2023 InMed Pharmaceuticals Inc.

Privacy Policy
Terms of Use
Legal Disclaimer

Find Us On:

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*

First name* Last name*

Email*

Consent

By providing your e-mail address, you consent to receive news, press releases, quarterly and annual reports, presentations and other information from InMed Pharmaceuticals Inc. You can unsubscribe at any time.